Prostate Cancer Tissue Array, With Adjacent Tissue And Normal Tissue, Including TNM And Pathology Grade, 28 Cases/72 Cores, Replacing BC19021|ヒト組織アレイ

掲載日情報:2015/08/07 現在Webページ番号:172725

US Biomax社は、豊富なラインナップの組織アレイ、組織切片(凍結、FFPE)を提供しているメーカーです。
US Biomax社のヒト組織アレイ(Prostate Cancer Tissue Array, With Adjacent Tissue And Normal Tissue, Including TNM And Pathology Grade, 28 Cases/72 Cores, Replacing BC19021)をご紹介します。

ヒト組織アレイは、ドナーからインフォームドコンセントを取得した組織を使用しています。
ドナーの組織は、HIV、Hepatitis B、Hepatitis Cが陰性であることを確認しています。
本製品は研究用です。研究用以外には使用できません。

ヒト組織アレイの価格

[在庫・価格 :2025年04月29日 20時55分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。
詳細 商品名
  • 商品コード
  • メーカー
  • 包装
  • 価格
  • 在庫
  • 法規制等
納期 文献数
Prostate cancer tissue array, with adjacent tissue and normal tissue, including TNM and pathology grade
2~3週間 ※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。 0
  • メーカーサイト
  • お問い合わせ
説明文
法規制等
保存条件 室温,暗所保存 法規備考
掲載カタログ

製品記事 TissueArray.Com社 組織アレイ(Tissue array) 選択ガイド
関連記事 TissueArray.Com社 パラフィン組織スライド/組織アレイの仕様変更につきまして

[在庫・価格 :2025年04月29日 20時55分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。

Prostate cancer tissue array, with adjacent tissue and normal tissue, including TNM and pathology grade

文献数: 0

説明文
法規制等
保存条件 室温,暗所保存 法規備考
掲載カタログ

製品記事 TissueArray.Com社 組織アレイ(Tissue array) 選択ガイド
関連記事 TissueArray.Com社 パラフィン組織スライド/組織アレイの仕様変更につきまして

目次に戻る

ヒト組織アレイの特長

Microarray Panel: Prostate carcinoma tissue microarray, containing 16 cases of adenocarcinoma, 8 adjacent tissue, 4 normal tissue, duplicate or triplicate cores per case
Cores: 72
Cases: 28
Layout: 9 cols × 8 rows
Core Diameter: 1.5 mm
Thickness: 5 µm
Quality Control: Anti-Prostate Specific Antigen (PSA) confirmed
Applications:

Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.

Notes: Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.

*Tissue Microarray Slide Types:

  • Unstained: unstained paraffin tissue microarray slide.
  • Trial: tissue microarray trial slide. 10% - 25% of cores missing. Good for titrating antibody dilution and experiment conditions. Limited numbers are available, to 2 per item per order. Test slides (tissue arrays with catalog numbers ending with 241 or 242) are recommended as a substitute.
  • H and E: Hematoxylin and Eosin stained tissue array slide.

目次に戻る

ヒト組織アレイの仕様表

Pos No. Sex Age Organ Pathology diagnosis Grade Stage Gleason Grade Gleason Score TNM Type †
A1 1 M 62 Prostate Adenocarcinoma 2 IV 3 3+3 T3N1M1b Malignant
A2 2 M 62 Prostate Adenocarcinoma 2 IV 3 3+3 T3N1M1b Malignant
A3 3 M 62 Prostate Adenocarcinoma 1 IV 3 3+3 T3N1M1b Malignant
A4 4 M 75 Prostate Adenocarcinoma 1 IV 2 1+2 T2N1M1c Malignant
A5 5 M 75 Prostate Adenocarcinoma 1 IV 2 1+3 T2N1M1c Malignant
A6 6 M 75 Prostate Adenocarcinoma 1 IV 2 1+4 T2N1M1c Malignant
A7 7 M 75 Prostate Cancer adjacent tissue AT
A8 8 M 75 Prostate Cancer adjacent tissue AT
A9 9 M 82 Prostate Adenocarcinoma (sparse) 3 II T2N0M0 Malignant
B1 10 M 82 Prostate Adenocarcinoma 3 II 5 4+5 T2N0M0 Malignant
B2 11 M 82 Prostate Adenocarcinoma 3 II 5 4+5 T2N0M0 Malignant
B3 12 M 40 Prostate Adenocarcinoma 3 IV 4 5+4 T2N1M1b Malignant
B4 13 M 40 Prostate Adenocarcinoma 3 IV 4 5+4 T2N1M1b Malignant
B5 14 M 40 Prostate Adenocarcinoma (sparse) 3 IV T2N1M1b Malignant
B6 15 M 40 Prostate Cancer adjacent tissue (smooth muscle and blood vessel) AT
B7 16 M 40 Prostate Cancer adjacent tissue (adenocarcinoma) 3 4 4+4 AT
B8 17 M 21 Prostate Normal prostate tissue Normal
B9 18 M 21 Prostate Normal prostate tissue Normal
C1 19 M 72 Prostate Adenocarcinoma 3 IV 5 5+5 T2N0M1 Malignant
C2 20 M 72 Prostate Adenocarcinoma 3 IV 5 5+5 T2N0M1 Malignant
C3 21 M 72 Prostate Adenocarcinoma 3 IV 5 5+5 T2N0M1 Malignant
C4 22 M 76 Prostate Adenocarcinoma 1 II 2 2+2 T2aN0M0 Malignant
C5 23 M 76 Prostate Adenocarcinoma 1 II 2 2+2 T2aN0M0 Malignant
C6 24 M 76 Prostate Adenocarcinoma 1 II 2 2+2 T2aN0M0 Malignant
C7 25 M 76 Prostate Cancer adjacent tissue (adenocarcinoma) 1 2 2+2 AT
C8 26 M 76 Prostate Cancer adjacent tissue (sparse adenocarcinoma) AT
C9 27 M 60 Prostate Adenocarcinoma 3 II 5 5+5 T2N0M0 Malignant
D1 28 M 60 Prostate Adenocarcinoma 3 II 5 5+5 T2N0M0 Malignant
D2 29 M 60 Prostate Adenocarcinoma with necrosis 3 II 5 5+5 T2N0M0 Malignant
D3 30 M 73 Prostate Adenocarcinoma 1 II 2 2+2 T2N0M0 Malignant
D4 31 M 73 Prostate Adenocarcinoma 1 II 2 2+2 T2N0M0 Malignant
D5 32 M 73 Prostate Adenocarcinoma 1 II 2 2+2 T2N0M0 Malignant
D6 33 M 73 Prostate Cancer adjacent tissue AT
D7 34 M 73 Prostate Cancer adjacent tissue AT
D8 35 M 43 Prostate Normal prostate tissue Normal
D9 36 M 43 Prostate Normal prostate tissue Normal
E1 37 M 87 Prostate Adenocarcinoma 3 II 4 4+5 T2N0M0 Malignant
E2 38 M 87 Prostate Adenocarcinoma 3 II 4 4+5 T2N0M0 Malignant
E3 39 M 87 Prostate Adenocarcinoma 3 II 4 3+5 T2N0M0 Malignant
E4 40 M 62 Prostate Adenocarcinoma 2 II 3 3+3 T2N0M0 Malignant
E5 41 M 62 Prostate Adenocarcinoma 2 II 3 3+3 T2N0M0 Malignant
E6 42 M 62 Prostate Adenocarcinoma 2 II 3 3+3 T2N0M0 Malignant
E7 43 M 62 Prostate Cancer adjacent tissue AT
E8 44 M 62 Prostate Cancer adjacent tissue AT
E9 45 M 63 Prostate Adenocarcinoma 2 IV 4 4+5 T2N1M1b Malignant
F1 46 M 63 Prostate Adenocarcinoma 2 IV 4 3+4 T2N1M1b Malignant
F2 47 M 63 Prostate Adenocarcinoma 2 IV 3 3+4 T2N1M1b Malignant
F3 48 M 75 Prostate Adenocarcinoma 3 III 5 5+5 T3N0M0 Malignant
F4 49 M 75 Prostate Adenocarcinoma 3 III 5 5+5 T3N0M0 Malignant
F5 50 M 75 Prostate Adenocarcinoma 3 III 5 5+5 T3N0M0 Malignant
F6 51 M 75 Prostate Cancer adjacent tissue AT
F7 52 M 75 Prostate Cancer adjacent tissue AT
F8 53 M 25 Prostate Normal prostate tissue Normal
F9 54 M 25 Prostate Normal prostate tissue Normal
G1 55 M 66 Prostate Adenocarcinoma 3 II 5 5+5 T2N0M0 Malignant
G2 56 M 66 Prostate Adenocarcinoma 3 II 5 5+5 T2N0M0 Malignant
G3 57 M 66 Prostate Adenocarcinoma with necrosis 3 II 5 5+5 T2N0M0 Malignant
G4 58 M 72 Prostate Adenocarcinoma 2 II 3 3+3 T2N0M0 Malignant
G5 59 M 72 Prostate Adenocarcinoma 2 II 3 3+3 T2N0M0 Malignant
G6 60 M 72 Prostate Adenocarcinoma 2 II 3 3+3 T2N0M0 Malignant
G7 61 M 72 Prostate Cancer adjacent tissue AT
G8 62 M 72 Prostate Cancer adjacent tissue AT
G9 63 M 62 Prostate Adenocarcinoma 3 II 5 5+5 T2N0M0 Malignant
H1 64 M 62 Prostate Adenocarcinoma 3 II 5 5+5 T2N0M0 Malignant
H2 65 M 62 Prostate Adenocarcinoma 3 II 5 5+5 T2N0M0 Malignant
H3 66 M 80 Prostate Adenocarcinoma 3 IV 5 5+4 T4N1M1c Malignant
H4 67 M 80 Prostate Adenocarcinoma 3 IV 5 5+4 T4N1M1c Malignant
H5 68 M 80 Prostate Adenocarcinoma 3 IV 5 5+4 T4N1M1c Malignant
H6 69 M 80 Prostate Cancer adjacent tissue (adenocarcinoma) 2 3 3+4 AT
H7 70 M 80 Prostate Cancer adjacent tissue (smooth muscle) AT
H8 71 M 27 Prostate Normal prostate tissue Normal
H9 72 M 27 Prostate Normal prostate tissue Normal
F 55 liver Hepatocellular liver cancer (tissue marker) 3 T3N0M0 Malignant

*For precise diagnosis, refer to pathology description.

目次に戻る

ヒト組織アレイのFAQ

目次に戻る

お問い合わせ先

(テクニカルサポート 試薬担当)

reagent@funakoshi.co.jp

製品情報は掲載時点のものですが、価格表内の価格については随時最新のものに更新されます。お問い合わせいただくタイミングにより製品情報・価格などは変更されている場合があります。
表示価格に、消費税等は含まれていません。一部価格が予告なく変更される場合がありますので、あらかじめご了承下さい。